Adage Capital Partners Gp, L.L.C. Repligen Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Repligen Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,000 shares of RGEN stock, worth $761,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$761,850% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
523Shares Held
58.8MCall Options Held
323KPut Options Held
667K-
Black Rock Inc. New York, NY7.57MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$769 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$534 Million0.05% of portfolio
-
United Capital Financial Advisers, LLC Newport Beach, CA2.76MShares$420 Million2.74% of portfolio
-
State Street Corp Boston, MA1.8MShares$275 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.46B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....